IMCR - Immunocore GAAP EPS of -$0.43 misses by $0.05 revenue of $55.09M beats by $2.91M
2023-05-10 08:54:18 ET
- Immunocore press release ( NASDAQ: IMCR ): Q1 GAAP EPS of -$0.43 misses by $0.05 .
- Revenue of $55.09M (+86.4% Y/Y) beats by $2.91M .
-
Cash and cash equivalents increased to £337 million ($417 million) as of March 31, 202 3
For further details see:
Immunocore GAAP EPS of -$0.43 misses by $0.05, revenue of $55.09M beats by $2.91M